Evidence map›Paper›PMID 32446986›Full record

ArticleMedecine et maladies infectieuses2020

Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?

R Amarsy, G R Pean de Ponfilly, H A Benmansour, H Jacquier, E E Cambau, B Mégarbane

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Medecine et maladies infectieuses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Skin health and disease · 2023
    Article
  4. Healthcare-associated infections in Dutch hospitals during the COVID-19 pandemic.Antimicrobial resistance and infection control · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R AmarsyInfection Prevention and Control Team, Lariboisière Hospital, University of Paris, Inserm IAME UMRS-1137, Paris, France.
G R Pean de PonfillyLaboratory of Microbiology, Lariboisière Hospital, University of Paris, Inserm IAME UMRS-1137, Paris, France.
H A BenmansourLaboratory of Microbiology, Lariboisière Hospital, University of Paris, Inserm IAME UMRS-1137, Paris, France.
H JacquierLaboratory of Microbiology, Lariboisière Hospital, University of Paris, Inserm IAME UMRS-1137, Paris, France.
E E CambauLaboratory of Microbiology, Lariboisière Hospital, University of Paris, Inserm IAME UMRS-1137, Paris, France.
B MégarbaneDepartment of Medical and Toxicological Critical Care, Lariboisière Hospital, University of Paris, Inserm UMRS-1144, Paris, France. Electronic address: bruno-megarbane@wanadoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease OutbreaksIntensive Care UnitsSerratia marcescensAdultCatheter-Related InfectionsCoinfectionCOVID-19Cross InfectionDrug Resistance, Multiple, BacterialFranceHumansInfection ControlPandemicsParisRisk FactorsSARS-CoV-2COVID-19Hospital-acquired infectionSerratia marcescens

Identifiers

PMID32446986
PMCPMC7241335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.